Erik Skullerud
Plus aucun poste en cours
Fortune : 342 $ au 30/04/2024
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Marco Renoldi | M | 67 | 8 ans | |
Per Anders Göte Samuelsson | M | 63 | 8 ans | |
Rainer Boehm | M | 63 | 4 ans | |
Pierre F. Dodion | M | 69 | - | |
Alexander Ernst | M | 57 |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | 3 ans |
Thomas Ramdahl | M | 68 | 1 ans | |
Ragnar Linder | M | 71 |
Amgen AB
Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | 4 ans |
Christine Wilkinson-Blanc | M | - | 1 ans | |
Kelly Constable | F | - |
Amgen AB
Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | 1 ans |
Sandra Jonsson | M | 51 | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Norvège | 7 | 70,00% |
Suède | 2 | 20,00% |
Allemagne | 1 | 10,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Erik Skullerud
- Réseau Personnel